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Highlights 
 The placental ―barrier‖ is permeable to many environmental chemicals 
 Effects of maternal exposure on the fetus may not appear until it reaches 
adulthood 
 Many of these long-term effects are mediated by epigenetic changes 
 Humans appear to be less sensitive to these effects than common test 
organisms 
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Abstract 
The uterine environment is often viewed as a relatively safe haven, being 
guarded by the placenta which acts as a filter, permitting required materials to enter 
and unwanted products to be removed. However, this defensive barrier is sometimes 
breached by potential chemical hazards to which the mother may be subjected. Many 
of these toxins have immediate and recognisable deleterious effects on the embryo, 
foetus or neonate, but a few are insidious and leave a legacy of health issues that may 
emerge in later life. Several substances, falling into the categories of metals and 
metalloids, endocrine disruptors, solvents and other industrial chemicals, have been 
implicated in the development of long-term health problems in the offspring 
following maternal and subsequent in utero exposure. The mechanisms involved are 
complex but often involve epigenetic changes which disrupt normal cell processes 
leading to the development of cancers and also dysregulation of biochemical 
pathways. 
 
Abbreviations 
5-mc: 5-methylcytosine 
AhR: aryl hydrocarbon receptor 
AKT: protein kinase B 
BPA: Bisphenol A 
CNS: central nervous system 
CS: Cigarette smoke 
DBP: dibenzo(α1) pyrene 
DES: diethylstilboestrol 
DNMT: N-methyltransferase  
E2: 17-β- oestradiol 
ED: endocrine disruptor 
ERE: oestrogen-responsive-elements  
EZH2: enhancer of Zeste homolog 2 (EZH2) 
GSK: glycogen synthase kinase 
HAT: histone acetyl transferase  
HDAC: histone deacetylase 
HOTAIR: (HOX transcript antisense RNA) 
IGF-1: insulin-like growth factor-1 
miRNA: micro RNA 
ncRNA: non-coding RNA 
PAH: Polycyclic aromatic hydrocarbons 
PCB: polychlorobiphenyl 
PCE: Tetrachloroethylene (perchloroethylene) 
PI3K: phosphoinositide 3-kinase 
TCDD: 2,3,7,8-tetrachlorodibenzo-p-dioxin 
TCE: trichloroethylene 
 
Keywords: polycyclic aromatic hydrocarbon; cigarette smoke; solvent; endocrine 
disruptor; metal; metalloid 
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1. Introduction 
One of the unanswered questions in toxicology is to what degree carcinogens 
affect the growing foetus as well as the mother and what the consequences might be. 
There are suggestions in the literature that cancer in early childhood is primarily 
caused by some event which occurs in utero but as carcinogens dysregulate many 
biological systems, other health problems could potentially be caused in later life. 
Such compounds might then also act as ‗developmental disruptors‘ (DDs), causing 
long-term dysfunction (cancer, chronic disease) in response to an event occurring 
many years previously. This review summarises key findings regarding potential in 
utero toxins and discusses possible mechanisms for the damage. 
 
1.1. Carcinogenesis 
Carcinogens act by several mechanisms. They may cause genomic changes, 
where the DNA sequence is altered, or non-genomic effects where the basic processes 
of translating DNA into proteins become dysfunctional. More recently, environmental 
chemicals called ‗endocrine disruptors‘ (EDs) have been described which affect 
steroid synthesis, degradation and function at the receptors. In utero exposure to EDs 
can lead to a consequent imbalance of androgenic/oestrogenic steroids and this has 
been linked in rodents with the appearance of tumours of their reproductive systems 
in later life [1]. The topic has been extensively reviewed and it is still unclear whether 
similar mechanisms occur in man although pollutants such as plasticisers and flame-
retardants have been implicated as potential causes of the increases seen in human 
breast and prostate tumours. As well as these pathways, epigenetics now seems to 
play a major role [2]. 
 
1.2. Epigenetics 
Rather than changes in the DNA sequence which alter the genotype, 
epigenetics affects how cells read the genes and involves the study of how 
environmental factors/compounds can  switch genes on or off, thus altering the 
phenotype. This can occur by a number of mechanisms (Figure 1). Firstly, there may 
be alterations in the methylation of the non-coding RNAs (ncRNAs). These are RNA 
molecules which are transcribed from DNA but their message is not translated into 
proteins. Instead, they are involved in regulation at the transcriptional and post-
transcriptional level. MicroRNAs (miRNAs) can also be altered. These are small 
nonprotein-coding RNAs that promote the degradation of target messenger RNAs, 
regulating both transcription and translation.  Since methylation changes their 
conformations it consequently alters their functions. Another major epigenetic 
mechanism involves re-modelling of chromatin, the complex of DNA and histone 
proteins, so that the microstructures of DNA or its associated chromatin proteins are 
modified rather than the code. Post-translational modification of the amino acids 
making up the histone proteins will alter their shape and function and many 
substitutions are known, including acetylation (lysine residues), methylation (arginine 
and lysine residues), phosphorylation (at serine and threonine residues) and 
ribosylation. The acetylation/deacetylation  of lysine by histone acetyl transferase 
(HAT) and histone deacetylase (HDAC) enzymes  has been  particularly investigated 
since the balance between the activities of the two enzymes is linked with cancer 
progression. 
DNA methylation is another well-studied phenomenon [3] where DNA N-
methyltransferases (DNMTs) catalyse the addition of a methyl group at the 5-carbon 
of cytosine to give 5-methylcytosine (5-mC). Usually, this occurs at  CpG sites where 
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a cytidine nucleotide is directly next to a guanidine nucleotide. These ‗islands‘ are 
mainly located in gene promoter regions and are involved in regulation of gene 
expression, although in embryonic stem cells 5-mC is also found in non-CpG 
contexts. Generally, when a CpG site in the promoter region is methylated, gene 
expression is repressed while gene demethylation by various processes, including 
hydroxylation, allows expression to occur. 
 
Clearly, carcinogens could act on the developing foetus by any of these 
mechanisms. Some epimutations appear to be corrected by normal reprogramming 
and are not transmitted to the offspring while others are not corrected and so can be 
inherited over several generations. It is not yet clear if the balance between 
transgenerational and non-transgenerational inheritance is the same in man as in 
rodent; this ratio may differ between the species [4]. Also, there is evidence that 
environmental influences and dietary factors which supply or transfer methyl groups 
for methylation reactions (eg folic acid) and flavonoids can alter degrees of 
methylation and affect DNA expression [5].  
 
2. Polycyclic aromatic hydrocarbons and cigarette smoke 
Polycyclic aromatic hydrocarbons (PAH) are known carcinogens and 
suspected endocrine disruptors. Prenatal exposure is common; a study (NHANES 
2001-2006) on 3189 children and adolescents found that total urinary PAH and 
naphthalene metabolites were associated with obesity in 6-11 year olds [6] but this 
association was less strong in adolescents (11-19 years). When dibenzo(α1) pyrene 
(DBP), a common PAH, was administered to pregnant mice, the offspring had 
increased mortality from T-cell lymphoblastic lymphomas and all those surviving to 
10 months had lung tumours while some had liver tumours. Both the foetal and 
maternal aryl hydrocarbon receptor (AhR) phenotypes seemed to be responsible for 
the range of effects [7] while short exposure to DBP during late gestation was more 
toxic than ingestion of DBP in the 3-week postnatal nursing period. Other cell types 
may be affected; the SETIL study looked at neuroblastoma cases (0-10 years old) in 
an Italian population and concluded that the risk was increased for children whose 
mothers had been exposed in pregnancy to hair dyes (0-17 month children, OR= 5.5, 
95%Cl: 1.0-29.3) or to aromatic hydrocarbons (OR= 9.2, 95%Cl: 2.4-34.3) [8]. 
Cigarette smoke (CS) is composed of over 4000 chemicals, some of which are 
carcinogenic. In mice, exposure to CS in utero from gestational day 1 to postnatal day 
21 led to low-birth weight offspring with alterations in protein, carbohydrate and lipid 
metabolism [9] while transplacental CS induced formation of lung adenomas in the 
offspring 8 months after birth [10]. The authors concluded, in what seems to be a 
general finding, that the carcinogenic response to CS varied depending on the 
developmental stage of exposure. Hakonsen et al [11] reviewed the extensive 
literature on this topic and concluded that in humans several aspects of reproductive 
health were involved. Prenatal exposure to maternal smoking was linked to an 
increased risk of cryptorchidism but a reduced risk of hypospadias while, in adult life, 
men had impaired semen quality. Both sexes had a tendency towards accelerated 
pubertal development. 
 
3. Solvents 
Prenatal exposure to high levels of alcohol leads to ‗foetal alcohol syndrome‘ 
where offspring have developmental delay. This condition can be recognised at birth 
and points to overall toxic effects on a range of cells. However, long-term effects also 
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occur. In rats, prenatal ethanol renders the offspring more susceptible to reproductive 
tract tumours when challenged with chemical carcinogens such as N-nitroso-N-
methyl urea and to hormones such as testosterone [12]. Exposure to alcohol in foetal 
life also increases susceptibility to mammary cancer in the adult animals, probably via 
increases in aromatase and hepatic insulin-like growth factor-1 (IGF-1) mRNA 
pathways [13]. In females, 17-β- oestradiol (E2)  and IGF-1 synergise to regulate 
formation of terminal end buds and ductal elongation during breast development in 
puberty and there is cross-talk between the intracellular signalling pathways mediated 
by the E2 and IGF-1 receptors. Both genomic and non-genomic mechanisms are 
involved [14]. If alcohol exposure in utero induces epigenetic modifications, probably 
via its known interactions with miRNAs [15], then this may lead to a cascade process 
where susceptibility to breast cancer is increased in later life  
The developing central nervous system (CNS) is very vulnerable to 
neurotoxicants and childhood brain tumours have been associated with exposure of 
either parent to solvents, especially benzene (OR=2.72) and other aromatics 
(OR=1.76) [16]. In what may be a similar example of CNS damage, prenatal exposure 
to solvents was associated with defective vision in the subsequent children [17]. A 
toxicological review of trichloroethylene (TCE) and meta analyses of epidemiological 
studies concluded that TCE is a renal carcinogen in man and probably causes 
developmental cardiac toxicity [18]. High levels of TCE contamination of 
groundwater were linked to the development of neural tube defects (OR=2.4) 
although the confidence intervals (CIs) had a wide range (0.6-9.6) [19].   
Tetrachloroethylene (perchloroethylene, PCE) is probably also carcinogenic as 
exposure appears to increase the risk of bladder cancer, particularly in workers in the 
dry cleaning industry. Prenatal exposure to PCE may be associated with adult sub-
clinical visual dysfunction, where colour discrimination is sub-optimal [20]. In a 
study on 831 subjects with prenatal exposure to PCE leached from water pipe linings, 
there was some evidence that risky behaviour in adult life (illicit drug use) was more 
common in those affected [21], suggesting subtle effects on brain development. Other 
systems may also be at risk as exposure to organic solvents around the time of 
conception increased the risk of childhood leukaemia in the offspring [22]. 
 
4. Endocrine disruptors 
These are compounds which interfere with normal endocrine homeostasis. For 
optimal function, hormone levels must be, as in the story about Goldilocks, ‗not too 
little, not too much but just right‘ and compounds which mimic natural oestrogens 
(most phenols have some oestrogenic activity because the oestrogen receptor is not 
very specific) have the potential to be disruptive. Prenatal exposure to both natural 
and synthetic oestrogens is known to be carcinogenic in man as well as increasing 
sensitivity to other carcinogens. 
Bisphenol A (BPA) is a ubiquitous contaminant of modern life as it is still 
widely used as a plasticiser and occurs at low levels in human biofluids. It is a known 
endocrine disruptor (ED). Prenatal exposure in rats to environmentally-relevant levels 
of BPA induced mammary gland neoplasms by postnatal-day 90 [23] while the 
mRNA and protein expression of the histone methytransferase Enhancer of Zeste 
homolog 2 (EZH2) was increased in adult mammary tissue and MCF-7 cells [24]. 
BPA therefore has epigenetic effects via increased mammary histone trimethylation 
and this pathway is a mechanism by which EDs can be linked with breast cancer. 
BPA is also able to bind to oestrogen-responsive-elements (EREs) and modify 
chromatin (by histone acetylation and methylation) leading to gene activation. This 
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occurs via a misregulation of the HOTAIR gene (HOX transcript antisense RNA) 
expression [25]. 
Diethylstilboestrol (DES), a synthetic nonsteroidal oestrogen, also shows an 
ability to influence both EZH2 and HOTAIR expression [25]. This compound is 
infamous for its ability to induce adenocarcinomas of the vagina and cervix in the 
female offspring of exposed mothers [26]. However, the number of affected 
individuals was very small considering the enormous amounts of DES that were 
routinely prescribed to pregnant women. The mechanism of this transplacental 
carcinogenesis is unclear although various active metabolites, DNA adducts and 
epigenetic scenarios have been proposed. Recently, evidence has emerged that DES 
has the ability to alter HOX gene expression [27]. Concern has been expressed over 
possible transgenerational transmission of DES-related epigenetic alterations. This 
certainly occurs in rodents but seems uncommon in humans [28]. Menstrual 
irregularities and possible infertility have been mooted but there appears no high risk 
of reproductive dysfunction, although further studies are needed for definitive results.  
The International Agency for Research on Cancer (IARC) has classified 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as a human multi-site carcinogen and 
polychlorobiphenyls (PCBs) as probable carcinogens although other dioxins and furan 
derivatives have not been so categorised owing to lack of evidence. PCBs, furans and 
dioxins are EDs in animals, influencing thyroid metabolism and also acting via the 
AhR pathway.  Although animal studies have demonstrated that prenatal exposure to 
dioxins or PCBs can alter the timing of pubertal onset, research in human populations 
has given equivocal results. Exposure before birth has been associated with an 
increased risk of infections in infancy, possibly reflecting some thyroid-mediated 
autoimmune dysfunction [29]. Some reports have suggested an increase in 
behavioural problems in school-age children [30]. 
 
5. Metal and metalloid carcinogens 
Both nickel and chromium compounds have carcinogenic potential in man and 
the toxicogenome of nickel (II) shows modifications of transcription factors which 
underlie the carcinogenic effects and could also lead to long-term damage [31]. 
Chromium (VI) compounds are known human carcinogens that produce reactive 
oxygen species (ROS) and primarily target the lungs. The ROS appear to be 
responsible for inducing the formation of tumours, probably via the activation of 
PI3K/AKT-dependent GSK-3beta/beta-catenin signalling and inhibition of apoptosis 
[32]. However, chromium can also induce post-translational modifications of histones 
and it affects many of the enzymes involved in epigenetic changes such as histone 
demethylases and methyltransferases. In cell culture, it has been shown to stimulate 
the formation of benzo[a]pyrene adducts with DNA [33] by cross-linking 
methyltransferase complexes to chromatin and has co-carcinogenic and co-mutagenic 
effects probably stemming from its interference with DNA repair processes. 
Although cadmium is classed as a renal toxicant, it is also a carcinogen of the 
gastrointestinal tract. It is known to cross the placental barrier and is linked to damage 
in neonates [34]. Exposure to cadmium was associated with distinct and specific  
patterns of DNA hyper- and hypo-methylation in both foetal and maternal DNA [35]. 
Cadmium and also arsenic have been shown to affect the glucocorticoid receptor 
signal transduction pathway by epigenetic modifications, correlating with the 
increased susceptibility to infections seen in human populations exposed prenatally to 
these metals [36]. 
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Arsenic is of particular concern as contaminated food and drinking water 
expose many millions of people to levels above those considered safe. 
Epidemiological studies have shown an association between arsenic exposure in utero 
and the future development of cancer as well as cardiovascular and respiratory 
diseases [37,38] and there are suggestions that humans are particularly susceptible 
[39]. In mice, arsenic is able to act as a complete carcinogen but, like cadmium, may 
also play a role as a co-carcinogen or co-promotor following in utero exposure [40]. 
During malignant transformations, arsenic appears to block cell differentiation 
thereby enhancing the survival of cancerous stem cells and creating an excess that 
may precipitate later oncogenic events and increase susceptibility to cancer [41]. 
Examination of umbilical cord blood from human neonates exposed to arsenic in 
utero showed increased expression of several miRNAs associated with signalling 
pathways related to cancer development and diabetes mellitus while there was a 
decrease in those involved with immune surveillance [42]. When methylation of 
neonatal cord blood-derived DNA was compared with maternal arsenic levels, loci in 
CpG islands had higher methylation levels in the highest exposed group. Some loci 
showed a linear dose-dependent relationship between methylation and arsenic 
exposure [43]. Reduction of histone acetylation (H4 at lysine 16) by direct binding to 
histone acetyltransferase (hMOF) has also been demonstrated [44]. 
 
6. Conclusions  
It is still not certain how far the results from rodents are applicable to humans. 
Particularly in the case of epigenetics, rodents seem to be quite susceptible although 
this may not necessarily be true for man [45]. The whole situation is made more 
complex because there are indications from both animal studies and some human 
findings that the timing of action of the carcinogen is critical to the results occurring 
in later life. This must of course reflect the precise mechanisms which are involved at 
a time when the biological processes of development are changing very rapidly both 
qualitatively and quantitatively. Further, there is some evidence in human populations 
and in animal work that epigenetic changes may be modified by external factors. 
Hence, whether any individual responds to in utero exposure to carcinogens by 
developing dysfunction in later life must represent a combination of genetic 
susceptibility, time of exposure, extent of exposure and dietary and environmental 
influences [46,47,48]. This important aspect of human health has received relatively 
little attention. However, increasing our understanding of the mechanisms underlying 
developmental disruption should lead to better therapeutic approaches for individuals 
exposed in utero to carcinogens. 
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